2024

Meta

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div>
<p class="has-drop-cap">Several major companies reported quarterly earnings this week, with 3M (NYSE: MMM), Bristol-Myers Squibb (NYSE: BMY), and Coursera Inc (NYSE: COUR) all seeing significant stock price movements following their announcements. As of the time of writing, all three stocks were trading actively on significantly higher-than-average volume.</p>
<h3 id="3m-nyse-mmm-stocks-see-largest-single-day-gain-in-over-36-years">3M (NYSE: MMM) Stocks See Largest Single-Day Gain in Over 36 Years</h3>
<p>3M shares surged 19.02% to $123.05 as of 11:38 AM EDT, marking the company’s largest single-day gain in 36 years. <br><br>The industrial conglomerate reported <a href="https://tokenist.com/3m-co-nyse-mmm-reports-1-93-adjusted-eps-in-q2-6-3-b-in-revenue/" rel="noopener noreferrer nofollow" class="deco-link">second-quarter sales</a> of $6.3 billion, down 0.5% year-over-year, but beat analyst expectations with adjusted <a href="https://tokenist.com/investing/how-to-value-a-stock/" class="deco-link" rel="noopener noreferrer nofollow">earnings per share</a> of $1.93, a 39% increase from the previous year. 3M’s GAAP operating income margin improved to 20.3%, while its adjusted operating income margin increased 4.4 percentage points to 21.6%.</p>
<p>3M’s new CEO boosted the profit forecast, citing cost cuts and demand recovery as key factors. The company raised its full-year 2024 adjusted EPS guidance to $7.00-$7.30, up from the previous range of $6.80-$7.30. <br><br>Despite the negative earnings per share over the trailing twelve months, the firm maintained its adjusted total sales growth forecast of -0.25% to +1.75% and returned $786 million to shareholders through dividends and share repurchases in the second quarter.</p>
<div class="cta-referral"><img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async">
 <div class="cta-referral__text">
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p>
 </div>
</div>
<h3 id="bristol-myers-squibb-nyse-bmy-rises-on-q2-beat-positive-phase-3-trial-results">Bristol-Myers Squibb (NYSE: BMY) Rises on Q2 Beat, Positive Phase 3 Trial Results</h3>
<p>Bristol-Myers Squibb stock rose 8.66% to $49.19 as of 11:38 AM EDT, following better-than-expected second-quarter results. The pharmaceutical giant reported revenue of $12.2 billion, up 9% year-over-year, with non-GAAP EPS growing 18% to $2.07. <br><br>The company’s blood thinner Eliquis saw a 7% increase in revenue to $3.4 billion, while its growth portfolio revenue jumped 18% to $5.6 billion.</p>
<p>BMY also announced positive <a href="https://finance.yahoo.com/news/bristol-myers-squibb-reports-second-105900862.html" target="_blank" aria-label="Phase 3 trial results (opens in a new tab)" rel="noopener noreferrer nofollow" class="deco-link">Phase 3 trial results</a> for cendakimab in treating eosinophilic esophagitis, a significant milestone for the company’s pipeline. <br><br>Despite a 19% drop in net income to $1.7 billion and a slight decrease in GAAP gross margin to 73%, the company raised its 2024 non-GAAP EPS guidance to $0.60-$0.90 and increased its revenue guidance to the upper end of the low single-digit range. The stock’s forward dividend yield stood at 4.54%, offering an attractive option for <a href="https://tokenist.com/investing/what-is-dividend-investing/" rel="noopener noreferrer nofollow" class="deco-link">income-focused investors</a>.</p>
<h3 id="coursera-inc-nyse-cour-surges-on-ai-related-growth">Coursera Inc (NYSE: COUR) Surges on AI-Related Growth</h3>
<p>Coursera’s stock price soared 39.14% to $10.31 as of 11:38 AM EDT after reporting strong second-quarter results and AI-driven growth. <br><br>The online education platform saw revenue increase 11% year-over-year to $170.3 million and added nearly 7 million new registered learners. Consumer revenue grew 12% to $97.3 million, while Enterprise revenue increased 8% to $58.7 million. The company’s Degrees segment also showed strong growth, with revenue up 14% to $14.3 million and the number of Degrees Students increasing 19% to 22,600.</p>
<p>Coursera surpassed 2 million enrollments in its generative AI courses and launched a record number of Professional Certificates with partners like Google Cloud, IBM (NYSE: IBM), and Meta (NASDAQ: META). <br><br>The company also introduced AI-powered innovations such as Coursera Coach and Course Builder, demonstrating its commitment to leveraging artificial intelligence in online education. Additionally, Coursera partnered with Microsoft on the Universal Access to Microsoft Skills Scholarship program. <br><br>Despite the significant stock price increase, Coursera’s market capitalization remained relatively small at $1.61 billion, reflecting the company’s growth potential in the expanding online education market.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe>
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p>
<h3 id="br"><br></h3>
<p>The post <a rel="noopener noreferrer nofollow" href="https://tokenist.com/stocks-to-watch-today-3m-bmy-and-coursera-inc/">Stocks to Watch Today: 3M, BMY, and Coursera Inc.</a> appeared first on <a rel="noopener noreferrer nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Stocks to Watch Today: 3M, BMY, and Coursera Inc.

Tabla de contenidos

Tokenist

Otros artículos publicados el 26 jul 2024

Rootstock Infrastructure Framework (RIF) Price Prediction 2025, 2026, 2027, 2028, 2029 and 2030

Floki Announces Valhalla Sponsorship for India’s Tour of Sri Lanka, Targeting 220M Viewers

BTCC Exchange Introduces Up to 50x Leverage on Over 300 USDT-Margined Trading Pairs (26 Jul)

XRP Poised for Parabolic Surge? Weekly Bullish Candle Ignites 800% Rally Speculation

SEC Approves Grayscale and ProShares Ethereum ETFs for NYSE Arca Listing

Cardano Launches Node 9.1.0: The Dawn of the Chang Hard Fork Era

¡Únete a nuestro boletín gratuito para recibir actualizaciones diarias de criptografía!